Peak Pharmaceuticals, Inc. Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended June 30, 2015
For the nine months, the company reported revenues of $751,313. Net loss was $1,893,779 against $2,492,464 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.75 USD | -6.25% | -6.25% | +116.76% |
1st Jan change | Capi. | |
---|---|---|
+116.76% | 78.47M | |
+12.71% | 3,150B | |
+10.98% | 87.56B | |
+8.10% | 80.72B | |
-16.04% | 52.81B | |
+35.76% | 51.91B | |
+30.86% | 46.06B | |
-31.32% | 42.52B | |
+78.94% | 41.62B | |
+2.37% | 28.24B |